BACKGROUND: Participation in clinical registries is nonrandom, so participants may differ in important ways from nonparticipants. The extent to which findings from clinical registries can be generalized to broader populations is unclear. METHODS AND RESULTS: We linked data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) registry with 100% inpatient Medicare fee-for-service claims to identify matched and unmatched patients with heart failure. We evaluated differences in baseline characteristics and mortality, all-cause readmission, and cardiovascular readmission rates. We used Cox proportional hazards models to examine relationships between registry enrollment and outcomes, controlling for baseline characteristics. There were 25,245 OPTIMIZE-HF patients in the Medicare claims data and 929,161 Medicare beneficiaries with heart failure who were not enrolled in OPTIMIZE-HF. Although hospital characteristics differed, patient demographic characteristics and comorbid conditions were similar. In-hospital mortality for OPTIMIZE-HF and non-OPTIMIZE-HF patients was not significantly different (4.7% versus 4.5%; P=0.37); however, OPTIMIZE-HF patients had slightly higher 30-day (11.9% versus 11.2%; P<0.001) and 1-year unadjusted mortality (37.2% versus 35.7%; P<0.001). Controlling for other variables, OPTIMIZE-HF patients were similar to non-OPTIMIZE-HF patients for the hazard of mortality (hazard ratio, 1.02; 95% confidence interval, 0.98 to 1.06). There were small but significant decreases in all-cause (hazard ratio, 0.94; 95% CI, 0.92 to 0.97) and cardiovascular readmission (hazard ratio, 0.94; 95% CI, 0.91 to 0.98). CONCLUSIONS: Characteristics and outcomes of Medicare beneficiaries enrolled in OPTIMIZE-HF are similar to the broader Medicare population with heart failure, suggesting that findings from this clinical registry may be generalized.
BACKGROUND: Participation in clinical registries is nonrandom, so participants may differ in important ways from nonparticipants. The extent to which findings from clinical registries can be generalized to broader populations is unclear. METHODS AND RESULTS: We linked data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) registry with 100% inpatient Medicare fee-for-service claims to identify matched and unmatched patients with heart failure. We evaluated differences in baseline characteristics and mortality, all-cause readmission, and cardiovascular readmission rates. We used Cox proportional hazards models to examine relationships between registry enrollment and outcomes, controlling for baseline characteristics. There were 25,245 OPTIMIZE-HF patients in the Medicare claims data and 929,161 Medicare beneficiaries with heart failure who were not enrolled in OPTIMIZE-HF. Although hospital characteristics differed, patient demographic characteristics and comorbid conditions were similar. In-hospital mortality for OPTIMIZE-HF and non-OPTIMIZE-HF patients was not significantly different (4.7% versus 4.5%; P=0.37); however, OPTIMIZE-HF patients had slightly higher 30-day (11.9% versus 11.2%; P<0.001) and 1-year unadjusted mortality (37.2% versus 35.7%; P<0.001). Controlling for other variables, OPTIMIZE-HF patients were similar to non-OPTIMIZE-HF patients for the hazard of mortality (hazard ratio, 1.02; 95% confidence interval, 0.98 to 1.06). There were small but significant decreases in all-cause (hazard ratio, 0.94; 95% CI, 0.92 to 0.97) and cardiovascular readmission (hazard ratio, 0.94; 95% CI, 0.91 to 0.98). CONCLUSIONS: Characteristics and outcomes of Medicare beneficiaries enrolled in OPTIMIZE-HF are similar to the broader Medicare population with heart failure, suggesting that findings from this clinical registry may be generalized.
Authors: Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde Yancy; James B Young Journal: Am Heart J Date: 2007-01 Impact factor: 4.749
Authors: Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow Journal: Eur Heart J Date: 2007-02-19 Impact factor: 29.983
Authors: Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young Journal: J Am Coll Cardiol Date: 2007-08-06 Impact factor: 24.094
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004
Authors: Emily P Zeitler; Anne S Hellkamp; Phillip J Schulte; Gregg C Fonarow; Adrian F Hernandez; Eric D Peterson; Gillian D Sanders; Clyde W Yancy; Sana M Al-Khatib Journal: Circ Heart Fail Date: 2016-01 Impact factor: 8.790
Authors: Uptal D Patel; Melissa A Greiner; Gregg C Fonarow; Hemant Phatak; Adrian F Hernandez; Lesley H Curtis Journal: Am Heart J Date: 2010-07 Impact factor: 4.749
Authors: Fenglong Xie; Lisandro D Colantonio; Jeffrey R Curtis; Monika M Safford; Emily B Levitan; George Howard; Paul Muntner Journal: Am J Epidemiol Date: 2016-09-19 Impact factor: 4.897
Authors: Larry A Allen; Adrian F Hernandez; Eric D Peterson; Lesley H Curtis; David Dai; Frederick A Masoudi; Deepak L Bhatt; Paul A Heidenreich; Gregg C Fonarow Journal: Circ Heart Fail Date: 2011-03-29 Impact factor: 8.790
Authors: Ankur Gupta; Larry A Allen; Deepak L Bhatt; Margueritte Cox; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Eric D Peterson; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow Journal: JAMA Cardiol Date: 2018-01-01 Impact factor: 14.676
Authors: Zubin J Eapen; Lisa A McCoy; Gregg C Fonarow; Clyde W Yancy; Marie Lynn Miranda; Eric D Peterson; Robert M Califf; Adrian F Hernandez Journal: Circ Heart Fail Date: 2015-03-06 Impact factor: 8.790
Authors: Adrian F Hernandez; Bradley G Hammill; Eric D Peterson; Clyde W Yancy; Kevin A Schulman; Lesley H Curtis; Gregg C Fonarow Journal: Am Heart J Date: 2010-03 Impact factor: 4.749
Authors: Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed Journal: Int J Cardiol Date: 2011-11-25 Impact factor: 4.164
Authors: Nancy Luo; Haolin Xu; Hani Jneid; Gregg C Fonarow; Renato D Lopes; Jonathan P Piccini; Anne B Curtis; Andrea M Russo; William R Lewis; Roland A Matsouaka; Christopher B Granger; Robert J Mentz; Sana M Al-Khatib Journal: Circ Heart Fail Date: 2018-10 Impact factor: 8.790